FDA recalls defective iOS app that injured over 200 insulin pump users

The FDA has announced a recall for version 2.7 of the t:connect iOS app by Tandem Diabetes Care, after 224 injury reports linked to the app causing insulin pumps to shut down prematurely due to a software issue. This has been classified as a Class I recall, indicating a risk of serious injury or death. Users are advised to update the app and monitor their devices closely, especially overnight. No deaths have been reported, but severe complications like diabetic ketoacidosis could occur.